Bangalore, 6th May 2024:VST ZETOR Private Ltd., the joint venture between VST Tillers Tractors Ltd and HTC Investments a.s (Owner of the “ZETOR” brand), announced the launch of three best-in-class higher HP tractors in the country today. Mr. Antony Cherukara, Managing Director, VST Zetor and Mr. Filip Soka, Vice Chairman, VST Zetor, jointly announced the launch in Bengaluru. The three new tractors launched in the range of 41 to 50 HP are VST ZETOR 4211, VST ZETOR 4511, and VST ZETOR 5011. These products are jointly developed by VST & ZETOR after rigorous testing and technological integration post taking valuable inputs from the farming community in India.
VST Zetor tractors developed at VST Zetor plant in India, features an indigenously made powerful, best-in-class DI Engine, fully constant mesh transmission with helical gears and VZmatic hydraulics. Its wider Platform, dual diaphragm clutch, optimum turning Radius, adjustable premium seat, dual-acting power steering and aerodynamic styling ensure ease of operation with desired comfort.
VST ZETOR tractors are best suited for a wide range of applications starting from land preparation to post-harvest operations. It is highly compatible with all heavy-duty non-agriculture tasks along with all primary, secondary tillage and haulage applications of Agriculture.
Mr. Antony Cherukara, MD VST Zetor, said “The launch of these tractors is a significant milestone as with these models we are entering into the 60% of the tractor industry of India, i.e. the higher HP segment. These tractors will help to strengthen our brand and build a much stronger tractor portfolio to cater to a wide range of farming applications and geographical market needs. VST Zetor has launched these tractors after thorough research and understanding of the requirements of the Indian farming community. These tractors are engineering marvels developed with the FAST FRUGAL and FUTURE READY approach of VST with TRUSTED, TIMELESS & TOUGH Identity of ZETOR, to offer technological efficiency for better earnings to the farmer. Going with its vision statement to emerge as the best solution provider for farm mechanization VST Zetor will introduce many more products in the Indian and International markets soon”.
Mr. Filip Soka, Vice Chairman of VST ZETOR, highlighted ZETOR’s 60-year legacy in India, renowned for its durability, reliability, and versatility. “Today, we fulfill the long-awaited desire to see ZETOR tractors in action on Indian soil. Our launch unveils three models tailored to meet the diverse needs of Indian farmers. Leveraging VST’s expertise in 4WD compact tractors, well-received in Europe, this collaboration promises to raise agricultural standards in India”.
“With a global presence in 130+ countries, our partnership with VST aims to strengthen our footprint in India, the world’s largest tractor market. Together, we empower Indian farmers with machinery embodying trust, timelessness, and toughness”.
Some of the Key features of the VST Zetor Tractors are –
* VZ Series Powerful Engines with Unit Cylinder Wet Liner Technology (UC-WLT)
* Helical Constant Mesh Gearbox with Forced Lubrication System
* Heavy Duty Rear Axle & Cold Forged Differential Gear
* Heavy Duty Hydraulics with Auto Depth & Draft Control (ADDC) and VZ-Matic
* Side Gear Shift, Under Hood Muffler, Heavy Duty Fenders
* Heavy-duty Box type Front Axle for application versatility.
* Spacious Wider Platform with Adjustable Deluxe Seat.
Taking operational comfort to the next level These Tractors have Integrated Car-like Headlamps, Compact packaging with under hood Muffler, a Stylish SMC Bonnet, a Stylish Dashboard with a Digital Cluster, a Heat Deflector, a Stylish & fully Covered Fenders, a Side Shift lever and GSPTO.
Bengaluru, 03 May, 2024 – Continuing with its 100-year celebration, MTR is back with the 3rd edition of its iconic Food Festival – MTR Karunadu Swada. This cherished food festival is being held on 4th and 5th May at Jayamahal Palace Convention Centre in Bangalore with an aim to delight the hearts of consumers and make them experience often-forgotten recipes from various parts of Karnataka.
The festival was inaugurated by Hon’ble Mr. Justice N. Santosh Hegde, Former Solicitor General of India. Under the leadership of MTR’s cuisine centre of excellence, over 50 home chefs are showcasing more than 100 dishes from six regions of Karnataka, including Uttara Karnataka, Kodagu, Dakshina Kannada, Kalyana Karnataka, Udupi and Hale Mysuru, taking the attendees on a sensory journey through the state’s culinary legacy.
MTR Karunadu Swada is a one stop celebration of Kitchens across Karnataka, using locally sourced ingredients, unique spice blends and recipes passed on through generations. On this occasion, the brand is extending this unique experience beyond the food festival by launching a special recipe book which is inspired by the dishes showcased at the festival.
The book features a curated collection of over 100 forgotten recipes from Karnataka, allowing people to recreate these forgotten dishes at home. Mr. Sunay Bhasin, CEO MTR, expressed his thoughts, “MTR Karunadu Swada is born out of MTR’s love for the food and culture of Karnataka. It is a celebration of Karnataka’s diverse flavours and our commitment to uphold the rich culinary heritage of the state. With evolving consumer needs and fast-paced lifestyles, we’ve inadvertently lost touch with traditional recipes and flavours that once defined our culture. This food festival serves as a bridge back to our roots, a heartfelt effort to preserve a piece of Karunadu heritage through these treasured dishes.”
In addition to the gastronomic experience, the event features celebrated Karnataka dance forms like Yakshagana and Dollu Kunitha, making it a complete cultural immersion, and highlighting Karnataka’s vibrant artistic traditions. Witness this culinary affair by securing your tickets, available exclusively on BookMyShow.com.
Bengaluru, Karnataka – May 3, 2024-Belenus Champion Hospitals celebrated the grand opening of its new Cardiology Specialty Clinic today, with a ribbon-cutting ceremony attended by prominent figures in healthcare and local governance. The clinic promises to revolutionize cardiac care with its advanced treatment options and comprehensive health packages,
Dr.RanjanShetty, Head of Cardiology at Manipal HAL Old Airport Road, and guest at the event, praised the new facility: “It’s inspiring to see how Belenus Champion Hospitals integrates the latest technology with patient-centered care. This clinic is set to elevate the standard of cardiac health services in our community.”
Manohar Reddy, local BJP President, emphasized the clinic’s role in enhancing community health: “This clinic represents a significant advancement in healthcare offerings available to our community. It’s a step forward in making high-standard healthcare accessible to all.”
Dr.Manjunath H, Founder of Belenus Champion Hospitals, highlighted the clinic’s commitment: “Our goal has always been to lead with innovation and compassion. The Cardiology Specialty Clinic is not just a medical facility, it’s a lifeline to those seeking hope and healing.”
Dr. Kishore Kumar M G, Co-founder, spoke about the integration of services: “We integrate clinical expertise with personalized care, ensuring that each patient receives the best possible outcome. Our new packages will cater to diverse needs, ensuring comprehensive care for all heart-related conditions.”
Dr. K. Bharathnandan Reddy, Consultant & Head Interventional Cardiology, and Dr.Prajith Pasam, Consultant Interventional Cardiology, introduced an exclusive Angiogram package priced at just ₹6,499, aimed at making critical diagnostic services more affordable.
Prashanth S Desai, CEO, outlined the future vision: “Today marks a key milestone in our journey towards excellence in healthcare. We are excited about the future and the pivotal role we play in shaping health services.”
Additionally, in an effort to prioritize patient health and early detection of cardiac issues, the clinic announced that anyone experiencing chest pain can walk in and receive a free ECG test, ensuring timely medical attention.
The Cardiology Specialty Clinic offers a range of specialized health packages, from basic screenings to comprehensive care plans, ensuring that patients receive tailored treatment that suits their specific needs. The clinic is equipped with cutting- edge technology and staffed by a team of renowned cardiologists and healthcare professionals dedicated to providing the highest standard of care.
ಜಯನಗರ ಐದನೇ ಬಡಾವಣೆಯಲ್ಲಿರುವ ನಂಜನಗೂಡು ಶ್ರೀ ರಾಘವೇಂದ್ರ ಸ್ವಾಮಿಗಳ ಮಠದಲ್ಲಿ ಭಕ್ತರಿಗಾಗಿ ಅನ್ನಸಂತರ್ಪಣೆಯ ಪ್ರಸಾದವನ್ನು ಪರಮ ಪೂಜ್ಯ ಶ್ರೀ 1008 ಶ್ರೀ ಸುಬುಧೇಂದ್ರ ತೀರ್ಥ ಶ್ರೀಪಾದಂಗಳವರ ಆದೇಶಾನುಸಾರ ಶ್ರೀ ಮಠದ ಹಿರಿಯ ವ್ಯವಸ್ಥಾಪಕರಾದ ಆರ್. ಕೆ. ವಾದೀಂದ್ರಾಚಾರ್ ಅವರ ನೇತೃತ್ವದಲ್ಲಿ ಮಹಾ ಮಂಗಳಾರತಿಯೊಂದಿಗೆ ಪ್ರತಿ ಗುರುವಾರದಂದು ಮಧ್ಯಾಹ್ನ 12 ರಿಂದ 2 ಗಂಟೆಯವರೆಗೂ ಸುಮಾರು 4,000 ಸಾವಿರಕ್ಕೂ ಮಿಗಿಲಾಗಿ ಹೆಚ್ಚಿನ ಭಕ್ತಾದಿಗಳಿಗೆ ವಿಶೇಷವಾಗಿ ಅನ್ನ ಸಂತರ್ಪಣೆ ಪ್ರತಿ ಗುರುವಾರವು ಭಕ್ತರ ಸಹಕಾರದಿಂದ ಪ್ರತಿಯೊಬ್ಬ ಭಕ್ತರಿಗೂ ಅನ್ನ ಸಂತರ್ಪಣೆಯ ಕಾರ್ಯಕ್ರಮವು ವಿಶೇಷವಾಗಿ ನಡೆಯುತ್ತಿದೆ ಎಂದು ಶ್ರೀ ನಂದಕಿಶೋರಾಚಾರ್ ಅವರು ತಿಳಿಸಿದ್ದಾರೆ ಅನ್ನಸಂತರ್ಪಣೆಯ ಶ್ರೀ ರಾಘವೇಂದ್ರ ಸ್ವಾಮಿಗಳ ಪ್ರಸಾದವನ್ನು ಪ್ರತಿಯೊಬ್ಬ ಭಕ್ತರು ಭಕ್ತಿಯಿಂದ ಸ್ವೀಕರಿಸಿ ಬಹಳ ಸಂತೋಷವನ್ನು ವ್ಯಕ್ತಪಡಿಸುತ್ತಾ ಶ್ರೀ ಗುರು ರಾಘವೇಂದ್ರ ಸ್ವಾಮಿಗಳ ಅನುಗ್ರಹಕ್ಕೆ ಪಾತ್ರರಾಗುತ್ತಿ ದ್ದಾರೆ. ಈ ಒಂದು ವಿಶೇಷವಾದ “ಅನ್ನದಾನದ”ಸೇವೆಯಲ್ಲಿ ಭಕ್ತಾದಿಗಳು ಕಾಣಿಕೆಯನ್ನು ಸಲ್ಲಿಸಿ ವಿಶೇಷವಾದ “ಅನ್ನದಾನ ಮಹಾದಾನ” ಸೇವೆಯಲ್ಲಿ ಭಾಗವಹಿಸಿ ಶ್ರೀ ರಾಘವೇಂದ್ರ ಸ್ವಾಮಿಗಳ ಫಲ ಮಂತ್ರಾಕ್ಷತೆ ಸ್ವೀಕರಿಸಿ ಗುರುಗಳ ಅನುಗ್ರಹಕ್ಕೆ ಪಾತ್ರರಾಗಬಹುದು. ಹೆಚ್ಚಿನ ಮಾಹಿತಿಗಾಗಿ- 08022443962-9945429129-9449133929-8660349906
Price Band fixed at ₹430 per equity share to ₹452 per Equity Share of face value of ₹2 each of Indegene Limited (“Equity Shares”)
Anchor Investor Bidding Date: Friday, May 03, 2024
Bid /Offer Opening Date: Monday, May 06, 2024
Bid/ Offer Closing Date: Wednesday, May 08, 2024
Bids can be made for a minimum of 33 Equity Shares and in multiples of 33 Equity Shares thereafter
The Floor Price is 215 times and the Cap Price is 226 times the face value of the Equity Shares.
L to R : VISHAL KANJANI EXECUTIVE DIRECTOR, NOMURA FINANCIAL ADVISORY AND SECURITIES (INDIA) PVT LTD, DR. SANJAY SURESH PARIKH EXECUTIVE DIRECTOR AND EXECUTIVE VICE PRESIDENT INDEGENE LTD, MANISH GUPTA CHAIRMAN AND CEO INDEGENE LTD, SUHAS PRABHU CHIEF FINANCIAL OFFICER INDEGENE LTD
Bangalore, May 2nd, 2024: Indegene Limited (the “Company”) proposes to open its initial public offering (“Offer”) on Monday, May 06, 2024, 2024. Bid/ Offer Closing Date will be Wednesday, May 08, 2024. Anchor Investor Bidding Date is one Working Day prior to Bid/Offer Opening Date, that is, Friday, May 03, 2024.
The Price Band of the Offer has been fixed from ₹430 per Equity Share to ₹452 per Equity Share. Bids can be made for a minimum of 33 Equity Shares and in multiples of 33 Equity Shares thereafter.
The Offer comprises of a Fresh Issue of equity shares aggregating up to ₹ 7,600 Million (The “Fresh Issue”) and an offer for sale of up to 23,932,732 Equity Shares (The “Offered Shares”), comprising of up to 1,118,596 Equity Shares by Manish Gupta aggregating up to such million, up to 3,233,818 Equity Shares by Dr. Rajesh Bhaskaran Nair aggregating up to such million, up to 1,151,454 Equity Shares by Anita Nair aggregating up to such million (Collectively with Manish Gupta and Dr. Rajesh Bhaskaran Nair, The “Individual Selling Shareholders”), up to 3,600,000 Equity Shares by Vida Trustees Private Limited (Trustee of Fig Tree Trust) in its capacity as partner of Group Life Spring aggregating up to such million, up to 2,657,687 Equity Shares by BPC Genesis Fund I SPV, Ltd. aggregating up to such million, up to 1,378,527 Equity Shares by BPC Genesis Fund I-A SPV, Ltd. aggregating up to such million and up to 10,792,650 Equity Shares by CA Dawn Investments aggregating up to such million (Collectively with Vida Trustees Private Limited, BPC Genesis Fund I SPV, Ltd And BPC Genesis Fund I-A SPV, Ltd., The “Investor Selling Shareholders” And Collectively With The Individual Selling Shareholders, The “Selling Shareholders” And Such Equity Shares, The “Offered Shares”).
The offer includes a Reservation of up to such number of Equity Shares, aggregating up to ₹125 Million, for subscription by Eligible Employees (“Employee Reservation Portion”). The Offer less the Employee Reservation Portion is hereinafter referred to as the “Net Offer”. A discount of ₹30 per equity share is being offered to Eligible Employees bidding in the Employee Reservation Portion (“Employee Discount”).
The Company intends to use the proceeds of the Fresh Issue utilize towards funding the Repayment/prepayment of indebtedness of one of its Material Subsidiaries, ILSL Holdings, Inc., funding the capital expenditure requirements of the Company and one of its Material Subsidiaries, Indegene, Inc. as well as funding the general corporate purposes and inorganic growth.
The Offer is being made through the Book Building Process, in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended (“SCRR”) read with Regulation 31 of the SEBI ICDR Regulations and in compliance with Regulation 6(1) of the SEBI ICDR Regulations, wherein in terms of Regulation 32(1) of the SEBI ICDR Regulations, not more than 50% of the Net Offer shall be available for allocation on a proportionate basis to Qualified Institutional Buyers (“QIBs”, and such portion, the “QIB Portion”) provided that our Company in consultation with the BRLMs, may allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBI ICDR Regulations (“Anchor Investor Portion”), of which at least one-third shall be available for allocation to domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Allocation Price. In the event of under-subscription or non-allocation in the Anchor Investor Portion, the balance Equity Shares shall be added to the Net QIB Portion. Further, 5% of the Net QIB Portion shall be available for allocation on a proportionate basis only to Mutual Funds and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIB Bidders (other than Anchor Investors) including Mutual Funds, subject to valid Bids being received at or above the Offer Price. However, if the aggregate demand from Mutual Funds is less than 5% of the QIB Portion, the balance Equity Shares available for allocation in the Mutual Fund Portion will be added to the remaining QIB Portion for proportionate allocation to QIBs. Further, not less than 15% of the Net Offer shall be available for allocation to Non-Institutional Bidders of which (a) one-third of such portion shall be reserved for applicants with application size of more than ₹200,000 and up to ₹1,000,000; and (b) two-third of such portion shall be reserved for applicants with application size of more than ₹1,000,000, provided that the unsubscribed portion in either of such sub-categories may be allocated to applicants in the other sub-category of Non-Institutional Bidders in accordance with the SEBI ICDR Regulations, subject to valid Bids being received above the Offer Price, and not less than 35% of the Net Offer shall be available for allocation to Retail Individual Bidders (“RIBs”) in accordance with the SEBI ICDR Regulations, subject to valid Bids being received from them at or above the Offer Price. Further, Equity Shares will be allocated on a proportionate basis to Eligible Employees applying under the Employee Reservation Portion, subject to valid Bids received from them at or above the Offer Price. All Bidders (except Anchor Investors) are required to mandatorily utilise the Application Supported by Blocked Amount (“ASBA”) process by providing details of their respective ASBA accounts (including UPI ID for UPI Bidders using UPI Mechanism) in which the Bid Amount will be blocked by the SCSBs or the Sponsor Banks, as applicable, to participate in the Offer. Anchor Investors are not permitted to participate in the Anchor Investor Portion of the Offer through the ASBA process.
The Equity Shares offered through the Red Herring Prospectus are proposed to be listed on BSE and NSE. The Company has received in-principle approvals from BSE and NSE for listing of the Equity Shares pursuant to their letters dated January 18, 2023 and January 19, 2023, respectively.
Kotak Mahindra Capital Company Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited and Nomura Financial Advisory and Securities (India) Private Limited are the book running lead managers (“Book Running Lead Managers” or “BRLMs”) to the Offer.
Capitalised term herein shall have the same meaning as ascribed to them in the Red Herring Prospectus dated April 26, 2024 (“RHP”) filed with the Registrar of Companies, Karnataka at Bengaluru (“RoC”).
Disclaimer INDEGENE LIMITED is proposing, subject to applicable statutory and regulatory requirements, receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its Equity Shares and has filed the draft red herring prospectus dated December 22, 2022 with SEBI (“the “DRHP”) and RHP with RoC on April 26, 2024. The RHP is available on the website of SEBI at http://www.sebi.gov.in, the websites of the Stock Exchanges i.e., BSE and NSE at http://www.bseindia.com and http://www.nseindia.com, respectively, on the website of the Company at http://www.indegene.com and is available on the websites of the BRLMs, i.e., Kotak Mahindra Capital Company Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited and Nomura Financial Advisory and Securities (India) Private Limited at https://investmentbank.kotak.com, http://www.online.citibank.co.in/rhtm/citigroupglobalscreen1.htm, http://www.jpmipl.com and http://www.nomuraholdings.com/company/group/asia/india/index.html, respectively. Potential investors should note that investment in equity shares involves a high degree of risk and for details relating to such risk, please see the section titled “Risk Factors” on page 25 of the RHP. Potential investors should not rely on the DRHP filed with SEBI, but instead rely on the RHP for making any investment decision. The Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (“U.S. Securities Act”), or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the Equity Shares are being offered and sold (i) within the United States only to persons reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act) pursuant to Section 4(a) of the U.S. Securities Act, and (ii) outside the United States in “offshore transactions” as defined in and in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales are made. There will be no public offering of the Equity Shares in the United States.
City Today News 
You must be logged in to post a comment.